Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial intelligence (AI). They note that Cascader also builds on the growing field of Oculomics—the use of advanced retinal imaging to uncover insights into systemic conditions such as cardiovascular disease, neurodegeneration, and dementia.

Headquartered in London, Cascader is focused on accelerating the translation of cutting-edge AI from research into real-world clinical tools. Cascader’s long-term mission is to develop a portfolio of AI tools to support earlier and more accurate detection of disease across the full spectrum of eye care and to further advance Oculomics as a foundation for precision medicine.